Table 2.
Variables | B | SE | Wald | OR | OR 95% CI | P-value | ||
---|---|---|---|---|---|---|---|---|
Lower bound | Upper bound | |||||||
Step 1 | Education ≤ 9 years | 1.11 | 0.54 | 4.26 | 3.01 | 1.16 | 7.64 | 0.038 |
Disease duration, years | 0.18 | 0.05 | 20.37 | 1.22 | 1.13 | 1.51 | <0.001 | |
DAS28-ESR | 0.39 | 0.16 | 5.30 | 1.46 | 1.06 | 2.15 | 0.022 | |
DMARDs usage, yes | −2.24 | 1.28 | 3.11 | 0.13 | 0.04 | 1.37 | 0.077 | |
Corticosteroids usage, yes | −0.76 | 0.45 | 3.06 | 0.48 | 0.21 | 1.09 | 0.080 | |
RF positive, yes | −0.66 | 0.39 | 2.79 | 0.63 | 0.13 | 1.74 | 0.095 | |
Anti-CCP antibody positive, yes | −0.97 | 0.46 | 5.02 | 1.03 | 0.17 | 1.57 | 0.025 | |
R2 | 0.380 | |||||||
Step 2 | Education ≤ 9 years | 1.11 | 0.55 | 4.24 | 3.06 | 1.1 | 8.41 | 0.041 |
Disease duration, years | 0.20 | 0.05 | 21.26 | 1.21 | 1.12 | 1.32 | <0.001 | |
DAS28-ESR | 0.38 | 0.16 | 5.43 | 1.45 | 1.16 | 2.17 | 0.020 | |
Anti-CCP antibody positive, yes | −0.99 | 0.47 | 5.12 | 1.07 | 0.16 | 1.68 | 0.021 | |
R2 | 0.379 |
OR odds ratio, CI confidence interval, DAS28-ESR Disease Activity Score in 28 joints-erythrocyte sedimentation rate, DMARDs disease-modifying antirheumatic drugs, RF rheumatoid factor, Anti-CCP anti-cyclic citrullinated peptide